Retention · healthcare · Southern EuropeJul 202610 min read350 words

Customer onboarding for Series B companies: scaling without breaking for healthcare and life sciences in Southern Europe

How Series B companies scale customer onboarding across regions and teams without losing the discipline that made it work at Series A. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Southern Europe.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Southern Europe. In this market, Southern European buyers reward relationship depth over transactional outreach, so the way you install customer onboarding has to be shaped to that reality from day one.

Series B is the stress test for customer onboarding. What worked at fifteen people fails at fifty unless the operating rhythm is deliberate.

The Series B move is to separate the model owner from the operators. One senior human owns strategy, time to first value, and the weekly review; a small team runs the machine.

Add a second geography or segment only when the first one is producing a defensible number for two full quarters. Not before.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Southern Europe it is compounded by the fact that relationship depth, not activity volume is what actually gates growth. Customer onboarding is only useful here when it is pointed at both constraints at once.

Governance appears at Series B — that is fine, provided it accelerates rather than slows. The test is whether reviews still make decisions or just distribute updates.

The Series B failure mode of customer onboarding is onboarding checklists that document handoffs instead of driving outcomes, amplified by headcount. Fix the root cause; do not paper over it with more people.

Compensation begins to matter now. Pay operators on time to first value outcomes, not on effort. Effort-based comp at Series B produces theatre.

A well-run customer onboarding function at Series B is the moat that survives to Series C. Companies that skip this discipline burn through raises trying to buy it back.

Concretely for healthcare and life sciences in Southern Europe: the healthcare teams that install this get past procurement instead of dying in it, and a single trusted Southern European relationship compounds into a regional beachhead. That is the reason it is worth installing customer onboarding deliberately for this market rather than importing a playbook designed for somewhere else.

SaaS onboardingcustomer onboardingactivationSaaS onboarding for series Bscaling GTMSaaS onboarding for healthcare and life sciencesSaaS onboarding in Southern Europehealthcare and life sciences growth in Southern Europe

Frequently asked questions

Retention · healthcare · Southern Europe — answered

Does customer onboarding work for healthcare and life sciences in Southern Europe?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Southern Europe, Southern European buyers reward relationship depth over transactional outreach. The healthcare teams that install this get past procurement instead of dying in it.
How does customer onboarding change at Series B?
Ownership separates from execution; operating rhythm gets more deliberate; governance appears.
When should we expand to a second region?
After the first region delivers two straight quarters of defensible time to first value.
What compensation model works for customer onboarding operators at Series B?
Outcome-linked on time to first value, not activity-based.
What is the Series B stress point?
Onboarding checklists that document handoffs instead of driving outcomes, amplified by headcount. Fix the root, not the symptom.
What is the Southern Europe-specific pitfall when running customer onboarding for healthcare?
Importing a playbook that was built for another market. In Southern Europe, Southern European buyers reward relationship depth over transactional outreach — the install has to reflect that.

Growth Broker editorial

Filed under retention · healthcare · southern europe

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call